Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
SILENCE THERAPEUTICS PLC
About SLN
Silence Therapeutics plc is a global clinical-stage biotechnology company engaged in transforming people’s lives by silencing diseases through precision-engineered medicines created with proprietary siRNA (short interfering RNA) technology. The Company leverages its mRNAi GOLD platform to create siRNAs designed to precisely target and silence disease-associated genes in the liver. The Company focuses on areas of high unmet medical need with programs advancing cardiovascular disease, hematology and rare diseases. Divesiran (SLN124) is its wholly owned siRNA product candidate designed to inhibit TMPRSS6 expression in the liver. Zerlasiran is a siRNA molecule designed for the treatment of cardiovascular disease associated with elevated Lp(a), a lipoprotein in the blood. In addition to its wholly owned clinical pipeline, it has a third siRNA product candidate from its mRNAi GOLD platform in Phase I development in an undisclosed indication through its collaboration with AstraZeneca.
Find out what a historical investment in SILENCE THERAPEUTICS PLC would be worth today using our SLN stock calculator.
Market Capitalisation
$288.13M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
188.51K
High today
$7.15
Low today
$6.08
Open price
$7.09
52-week high
$8.40
52-week low
$3.86
Ready to start your investing journey with Stake?
Open an accountHow do I buy SLN shares in Australia?
Buying SLN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in SILENCE THERAPEUTICS PLC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in SLN
What is the ticker symbol of SILENCE THERAPEUTICS PLC?
The ticker symbol for SILENCE THERAPEUTICS PLC is SLN.
How much is one share of SLN?
One share of SLN is valued at $6.12 as of 17 May 2026.
What is the market capitalisation of SILENCE THERAPEUTICS PLC SLN?
As of 17 May 2026 SILENCE THERAPEUTICS PLC has a market cap of $288.13M.
What is the 52-week high for SILENCE THERAPEUTICS PLC stock?
The SILENCE THERAPEUTICS PLC 52-week high stock price is $8.40.
What is the 52-week low for SILENCE THERAPEUTICS PLC stock?
The SILENCE THERAPEUTICS PLC 52-week low stock price is $3.86.
Can I buy SLN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SLN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SLN on Stake
- Buy SLN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of SLN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
SLN related stocks